Skip to main content
editor@jprims.in
9343055451
e-ISSN: 3049-1681
Journal of Pharmaceutical Research and Integrated Medical Sciences

Journal of Pharmaceutical Research and Integrated Medical Sciences

Anu viral Patel

Author Profile
SAL Institute of Pharmacy, Ahmedabad, Gujarat – 380060, India.
3
Publications
1
Years Active
9
Collaborators
102
Citations

Publications by Anu viral Patel

3 publications found • Active 2026–2026

2026

3 publications

Development, Optimization and Characterization of Amlexanox-Loaded Electrospun Nanofibers for Oral Mucosal Drug Delivery

with Zalak Bhupendrakumar Patel, Jignesh Modi, Nishith K. Patel, Ravikumar R. Patel, Kalubha Shivubha Zala, Ketan Shantilal Rathod, Rakeshkumar Pravinbhai Patel, Jahanviben Chandrakant Patel
10/5/2026
pp. 1-18

Amlexanox-loaded electrospun nanofibers were investigated as a buccal drug-delivery system for local management of aphthous ulceration. Amlexanox was a pale-yellow crystalline, odourless, metallic-tasting powder and showed a practical melting point of 333.0 °C. UV spectrophotometric analysis in phosphate buffer pH 6.8 showed λmax at 244 nm. PVA, PVP K30 and PVP K90 were screened by preliminary electrospinning trials. Drug-loaded PVP K30 did not sustain Taylor-cone formation, whereas PVP K90 supported drug-loaded electrospinning; A29 and A30 showed prolonged Taylor-cone formation and drug entrapment of 73.57% and 76.84%, respectively. A two-factor, three-level optimization study evaluated PVP K90 concentration and tip-to-collector distance. For AF1–AF10, entrapment efficiency ranged from 70.4±2.3% to 81.6±2.0%, 12-h cumulative diffusion from 47.32% to 83.73%, and 24-h cumulative diffusion from 82.16% to 97.82%. The quadratic model for entrapment efficiency was significant (F=9.15, p=0.0260; R²=0.9196). AF11 showed 59.70% diffusion at 12 h and 91.58% at 24 h. The experimental dataset demonstrates the feasibility of PVP K90-based amlexanox nanofibers, while the coded-versus-actual optimization matrix and prospective stability study require reconciliation/completion before definitive optimized-product claims.

Evaluation of Anti-Arthritic Activity of Bioactive Fractions of Rumex hastatus in Experimental Models of Rheumatoid Arthritis

with Ishita Basera, Ravikumar R. Patel, Ketan Shantilal Rathod, Zalak Bhupendrakumar Patel, Jahanviben Chandrakant Patel, Rakeshkumar Pravinbhai Patel, Kalubha Shivubha Zala
9/25/2026
pp. 109-120

The present study evaluated the acute oral toxicity and in vivo anti-inflammatory activity of the methanolic leaf extract of Rumex hastatus (RHLM). In the acute toxicity study, mice received RHLM at 250, 500, 1000 and 2000 mg/kg and were observed for 14 days. No mortality or notable adverse behavioural changes were reported up to 2000 mg/kg, and body-weight gain remained comparable with the control group. Hematological indices and biochemical markers of hepatic and renal function showed no notable treatment-related alterations. Anti-inflammatory activity was evaluated in carrageenan- and formalin-induced rat hind-paw edema models. In the carrageenan model, RHLM at 200 and 400 mg/kg reduced paw edema over 5 h; at 5 h, percentage inhibition was 36.12±1.75% and 61.42±1.03%, respectively, compared with 61.58±1.34% for indomethacin (10 mg/kg). In the formalin model, RHLM reduced edema across the six-day observation period, with the 400 mg/kg dose showing the greatest effect. On day 6 at 3 h, inhibition was 57.55±3.45% with RHLM 400 mg/kg, compared with 55.21±3.05% for diclofenac (5 mg/kg). These findings indicate that RHLM was well tolerated in the reported acute toxicity study and demonstrated marked anti-inflammatory activity, particularly at 400 mg/kg.

Analytical Profiling of Indapamide and Losartan Potassium: UV–Visible, FTIR, and Chromatographic Characterization for Simultaneous Analysis

with Jahanviben Chandrakant Patel, Ishita Basera, Ravikumar R. Patel, Ketan Shantilal Rathod, Zalak Bhupendrakumar Patel, Rakeshkumar Pravinbhai Patel, Kalubha Shivubha Zala
9/25/2026
pp. 96-108

Background: Simultaneous analysis of drug combinations requires prior understanding of the individual physicochemical and spectroscopic behavior of each analyte and systematic optimization of chromatographic selectivity. Indapamide (IND), a thiazide-like diuretic, and losartan potassium (LOS), an angiotensin II receptor blocker, differ markedly in aqueous solubility, lipophilicity and UV absorption behavior. Objective: The present work profiled IND and LOS by preliminary physicochemical tests, FTIR, UV–visible spectrophotometry and RP-HPLC to establish analytical conditions suitable for simultaneous determination. Methods: Melting point and solubility were evaluated, FTIR spectra were interpreted for characteristic functional groups, and methanolic UV spectra were scanned from 200–400 nm. Chromatographic screening was performed on a C18 column (250 × 4.6 mm, 5 µm) using seven mobile-phase trials. Results: IND showed a melting point of 163–165°C and LOS 262–264°C. Characteristic FTIR bands supported identity of both analytes. UV maxima were approximately 236 nm for IND and 206 nm for LOS; an overlay supported 214 nm as the common HPLC detection wavelength. The optimized chromatographic system consisted of phosphate buffer pH 3.0:acetonitrile (40:60, v/v) at 1.0 mL/min. IND and LOS eluted at approximately 3.74 and 6.98 min, respectively, with a resolution of 11.22. Calibration responses were linear over 0.75–7.5 µg/mL for IND and 25–250 µg/mL for LOS, with R² values of 0.9997 and 0.9996. Conclusion: Complementary UV, FTIR and chromatographic profiling provided a rational basis for simultaneous analysis of IND and LOS and established a selective RP-HPLC condition for their quantitative determination.